Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuroprotection and repair in multiple sclerosis.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: a comparative study.
Multiple Sclerosis: Current Knowledge and Future Outlook.
Proteasome Inhibitors: A New Perspective for Treating Autoimmune Diseases.
Simultaneous Pml-Iris After Discontinuation of Natalizumab in A Patient With MS.
Restless Legs Syndrome in Multiple Sclerosis.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia.
Resolvin d1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses.
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.
[Current state of research on multiple sclerosis].
Sustained TNF production by central nervous system infiltrating macrophages promotes progressive autoimmune encephalomyelitis.
Brainstem manifestations in neuromyelitis optica: a multicenter study of 258 patients.
Perforin-Positive Dendritic Cells Exhibit an Immuno-regulatory Role in Metabolic Syndrome and Autoimmunity.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci.
The Evidence for a Beneficial Role of Vitamin A in Multiple Sclerosis.
CNS inflammation other than multiple sclerosis: How likely is diagnosis?
Pathologic heterogeneity persists in early active multiple sclerosis lesions.
Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Smoking increases the risk of multiple sclerosis in Queensland, Australia.
Patients' perspectives on quality of mental health care for people with MS.
Multiple sclerosis and inflammatory bowel diseases: what we know and what we would need to know!
Severe relapses under fingolimod treatment prescribed after natalizumab.

Pages